Ligand-targeted therapeutics (LTTs) are a successful means of improving the selective toxicity of anticancer therapeutics. A radioimmunotherapy, an immunotoxin and an immunoconjugate have received ...
Get article recommendations from ACS based on references in your Mendeley library. Pair your accounts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results